Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a “Lot”. Full details of each Lot are contained in section II.2 of this notice.
- Procurement
- Cytokine Modulators
- Published
- 11 Feb 2021
- Status
- complete
- CPV
- 33600000 — Pharmaceutical products
- Tender period
- —
Awards
- Sandoz Ltdactive—
- Pfizer Ltdactive—
- Biogen Idec Ltd.active—
- Pfizer Ltdactive—
- Merck Sharp & Dohmeactive—
- Celltrion Healthcare United Kingdom Limitedactive—
- Biogen Idec Ltd.active—
- Sandoz Ltdactive—
- Celltrion Healthcare United Kingdom Limitedactive—
- AbbVie Ltdactive—
- amgen ltdactive—
- Fresenius Kabi Limitedactive—
- Biogen Idec Ltd.active—
- Sandoz Ltdactive—
- Accord-UK Ltdactive—
- medac Pharma LLPactive—
- Accord UK Ltdactive—
- Nordic Pharma Ltdactive—
- Nordic Pharma Ltdactive—
Other notices in this procurement
This is the only notice on record.
FAQs about this notice
What type of notice is this?
This is a award,contract published via Find a Tender on 11 Feb 2021.
Which procurement does this notice belong to?
It is part of "Cytokine Modulators", published by The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS").
Has this notice resulted in an award?
19 awards are recorded on this notice, including to Sandoz Ltd.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable